NEEL AUGUSTHY
*************@*******.***
VALUE PROPOSITION
q P&L leader with track record of impact in Fortune 50 Pharma, Medical and Consumer Product companies, driving transformations to the tune of $250m and EBITDA uplift of $100m.
q Versatility and the ability to drive sustainable change in managing different mandates be that a Start-up, a Multinational or a SME. q Proven change agent with the ability to navigate multiple countries, regions and cultures (Europe, Asia & ANZ) with a track record of driving employee experience and 98%+ retention. q Entrepreneurial & Creative mindset with the drive and passion for designing win-win solutions. PROFESSIONAL EXPERIENCE
Aug20 – Now Maker Lab – CFO (Global) – Full Service Media Agency q Interim CFO alongside Legal & Compliance responsibilities q Helped fix their process as well as switch over from cash basis to accrual basis q Assisted with financials and negotiations of a majority stake sale to a Global Media Group q Setting up their policies and procedures including multiple country legal entity setups and reporting cadence
q Assisting with HR in the absence of an HR Director Nov18 – Now VADN Group – Director (Singapore) – Strategy & Operational Consulting Clients serviced: Mental Health Tech (Singapore), Fitness & Financial Management Tech (US), Beverage Company (Singapore), Health Tech SaaS Platform (Singapore), Online to Offline Service Portal (US), Commodities & Automotive Trader (Dubai & West Africa), Aged Care Software Provider
(EMEA/Australia), Medtech VC Fund (APAC)
q Redesigned an Aged Care Company’s Finance, Hospital and Charity offerings as SME q Advisory Board Member & CEO Coach for the Aged Care SW Provider. Helped them assess their EMEA team capabilities and leadership gaps at the HQ level in Australia q Healthcare B2B SaaS Platform - development design & advisory. Project Managed the design and development. Board member of the company. q I helped a SaaS start-up at the crossover of fitness and fintech redesign their go-to-market strategy from a B2C model to a B2B2C model that helped them gain traction through insurance providers and corporate health benefit plans. They eventually sold out to a fintech company q For a Commodities & Automotive Trader I analysed their entire business down to individual client level. Designed a plan taking into account their leadership capabilities, the improvements required there in and the digitization of their sales channel (commodities) q Market entry / GTM (go-to-market) – Ideation, Facilitation & Consulting for various start-ups q Financial structure, business case assessment/development guidance for various start-ups q Advisory on Pricing Strategy, Sales channels B2C vs B2B, Funding needs assessment etc q Competition / Product Analysis & Customer Assessments to revitalise sales growth q Fraud Detection and development of mitigation plans q Leadership Team & HiPo assessments, Key development focus areas for various orgs q Organisational and Process assessment and redesign q Deal Advisory & Investment Evaluations for a Medtech VC Fund being setup in Singapore Nov16 – Nov18 MEDTRONIC - CFO SEA & Emerging Markets (Singapore) q Undertook a 2-year project to transform and grow Medtronic SEA, This was achieved through data analytics, cost management, process improvement and strengthening the overall bond within the region across the functional, sales and marketing teams q Provided leadership, direction and management of the finance and accounting teams across SEA
q Strategic advisor to the SEA leadership team as well as the APAC team q Networking both internally and externally to drive business growth, banking relationships and vendor/client relationships
q Build a high performing, collaborative and team across SEA q Interim GM for SEA for a period of 6 months after the departure of the incumbent q Managed the SEA financial rolling forecasts, annual budget process, price-volume mix, ROI and investment payback
q Oversaw the preparation of management & statutory reporting across SEA (10+ markets) EDUCATION
MBA (Strategy & Mkt)
London Business School
2007-2009
CPA
2006
Masters Applied Finance
Macquarie University
2000-2002
B Accounting & Finance
Uni New South Wales
1996-2000
CERTIFICATION
Software Engineering
General Assembly
2019
VC Financing
Kauffman Fellows /
Techstars
2021
AWARDS
2014 Young Business
Leader of the Year (CPA
Australia)
Mentoring Women in
Business (Cherie Blair
Foundation) – Awarded
certificate for mentoring
women in business
Standards of
Leadership Award (J&J)
– for the Acquisition of
BioSeal
NATIONALITY
Australian, Singapore PR
USA - E-3 Visa Eligibility
(no sponsorship required
only a formal job offer)
transformation, restructure, productivity, continuous improvement, efficiency, m&a, licencing, acquisitions, investments, investment management, supply chain, cfo, finance director, regional cfo, business partnering, project management, credit management, credit control, people management, team management, people development, mentoring, mentor, mergers, team building, performance improvement, warehousing, logistics, research & development, research, development, r&d, business development, controllership, compliance, executor, project management, gaap, ifrs, sox, fcpa, analysis, business partnering, strategy, strategy development, cost analysis, cost management, distribution, warehousing, logistics, customer service, sales effectiveness, sfe, sales force effectiveness, procurement, purchasing, general manager, general management, coo, chief operating officer, chief financial officer, project analysis, operations management, forex, exposure, risk management, organisation design, customer service, profitability, strategic alliances, tax optimisation, profitability, negotiation, contract management, contract negotiation, divestiture, fx, analytics, human resource management, legal contracts, distributors, indirect purchasing, sourcing, transfer pricing, tp, cash management, business structuring, accounting, fp&a, data analysis, executive management, strategic recommendations, financial planning, long range plan, commercial insight, business plan targets, exceed, frameworks, senior management, external partners, stakeholders, organisational design, org design, organisational structuring, stakeholder management, emerging markets, consumers, management skills, stewardship, brands, sustainability, impact, apply q Ensured compliance to SOX, IFRS, FCPA and Tax requirements across markets and corporate standards q Restructured / Transformed 6+ markets setting up org structure, policies, processes, SOPs, integrated operating model q Drove topline growth 12%+ to 25%+ over two years, taking the region to ~$350m+, improved profitability to 35~39% q Drove 10%+ cost reduction through vendor terms, process optimisation and continuous improvement q Drove analysis and application of Sales Force Effectiveness (SFE) q Drove growth through a Key Account Management (KAM) setup across all 6 key SEA markets q Developed Market Access & Expansion strategies (with sales) drove 5% share increase and 8~10% sales growth q Managed performance across 130+ distributors including contract negotiation and SLA management q Setup an Analytics Hub in Singapore, redesigned and reorganised the Finance function across SEA that looked at leading indicators of market movements and their impact on our performance and drove decision making q Generated cashflow and P&L room through negotiated settlements on long overdue AR ($100m) q Mentor to many of the finance members in APAC Finance as well as peers in SEA Team size was ~35 people directly in finance, indirect was ~400. Reported to the APAC CFO. SEA Remit (TH, VN, ID, MY, SG, PH, 4+ minor markets). Post transformation completion the residual role by design was a much smaller role. May09 – Nov16 JOHNSON & JOHNSON Various CFO roles across (APAC) Oct13 – Nov16 CFO APAC – (CLS) Enterprise Delivery Vertical (Singapore) Oct12 – Nov16 CFO Supply Chain - Medical Devices (Singapore) Jan10 – Oct12 CFO APAC BD R&D - Medical Devices (China) May09 – Sep10 CFO APAC Cordis & CFO Philippines Medical (Philippines) q Full suite CFO responsibilities for Medical Philippines, Medical R&D BD, RDC CLS & Cordis ($1b+) operations q Leadership roles driving change and growth across multiple business lines and geographies q Ensured compliance to SOX, IFRS, FCPA and Tax requirements across APAC markets q Managed the Country / Region rolling forecasts. Quarterly, Annual and Long Range planning & budget process, price- volume mix, ROCE and paybacks
q Managed a portfolio of 160+ distribution/warehousing nodes ($12b+ in sales) covering Pharma, Medical & Consumer q Instrumental in negotiating a deal that helped bring down OCD distributor margins from 40%+ to 7% q Board Member of the APAC Investment Review Board for M&A R&D transaction and J&J Philippines q Successfully acquired BIOSEAL, a Guangzhou based Biologics company a first for J&J Medical in APAC in 130yrs+ q J&J Medical embarked on an ambitious program of creating products for the APAC region. I helped devise and put in place the strategy for this new operating model in Suzhou (China) & Mumbai (India) q Managed IP / tax risk for J&J source/manufacturing COs, Mumbai & Suzhou R&D centres. Generated savings ~$25m+ q Lead the design and setup of the CLS vertical in Asia (serving $12b+ in sales). Over a two-year period, we became financially self-sufficient through continuous improvement programs, org design, automation programs and vendor/distributor management
q Annual savings of $20m+ delivered through cost improvement, working capital and cashflow management q Setup revenue & profit maximisation (~$50m+) through Cost-to-Serve and Channel Optimisation q Drove savings (~$10m YoY) through the analysis of SC variances, minimised SLOB down to 1.2% vs 15% trend q Managed Transfer Pricing (TP) of products passing through the RDC (60,000+ SKUs) q Reduced the order-to-border days from 10 to 2.5 days, through financial, operational and process redesign (Lean) q Developed the Centre of Excellence (COE) for Hedging (14+ currencies) selling in local currencies to all markets q Created a global playbook for J&J Logistics, Warehousing & Distribution for the Cordis divestiture to Cardinal Health q Implemented automation projects such as automated order fill scanning and redressing capabilities q Valuation, Analysis and DD of M&A targets including product licencing & distribution (toll vs local manufacturing) q Instrumental in the development of Orthopaedics Instrument Sets which led to an 89% cost reduction q Oversaw SAP roll-out of J&J Medical Philippines
q Devised Philippines KAM Strategy, sales & profit grew 16% & 21% YoY, setup robust processes, S&OP process and account level analytics
q Grew Cordis sales & profit 12% & 15% YoY, with a back drop of a block buster product at the end of life q Passed all internal & external audits at J&J and rectified failures of FCPA audits (Philippines) q Led the SAP implementation for J&J Medical Philippines q Developed a Performance Scorecard reducing time to analysis from 2 weeks to 1 day for Cordis APAC q Setup the entire M&A R&D finance team in China from ground up q 98% people retention track record at J&J for 7.5 years, Chairman of the talent, training & dev council for SEA Finance Team sizes ranged from 15 ~ 40 direct finance, indirect team sizes ranged from 200 ~ 500. Reported either to the Global CFO for the respective verticals I managed or APAC CFO. APAC Remit (AU, JP, CN, HK, TW, VN, ID, MY, SG, NZ, IN, TH, PH and 10+ minor markets). Left for an opportunity to transform a business. Feb06 – Apr09 ANLYTIKA LIMITED - Managing Director (UK) Clients serviced: Fujitsu Services (UK & Germany), Shire Pharmaceuticals (UK), GSK PLC (UK) Shvydko
(Ukraine), Trillium Partners (UK)
Feb96 – Jan06 MERCK & CO (MSD) - Fin Biz Partner (Mkt & BD) & JV Controller (ANZ) RAILCORP - Internal Strategy & Business Consultant (Australia) SITA INC - Snr Analyst APAC (Australia, projects across APAC) EDS INC - Analyst (Australia)
GRANT THORNTON STAPLETON PARTNERS - Accountant (Australia)